Response to letter regarding article, impact of implantable cardioverter-defibrillator, amiodarone, and placebo on the mode of death in stable patients with heart failure: Analysis from the sudden cardiac death in heart failure trial

Douglas L. Packer, Robert P. Frantz, Jordan M. Prutkin, Jeanne E. Poole, Anne S. Hellkamp, Freda Wood, Steve E. McNulty, Joseph G. Rogers, Daniel B. Mark, Kerry L. Lee, L. Brent Mitchell, Robert C. Bernstein, John P. Boehmer, Mark D. Carlson, Jill Anderson, Gust H. Bardy, George W. Johnson, Mary Norine Walsh

Research output: Contribution to journalLetter

Original languageEnglish (US)
Pages (from-to)e487
JournalCirculation
Volume122
Issue number15
DOIs
StatePublished - Oct 12 2010

All Science Journal Classification (ASJC) codes

  • Cardiology and Cardiovascular Medicine
  • Physiology (medical)

Cite this

Packer, D. L., Frantz, R. P., Prutkin, J. M., Poole, J. E., Hellkamp, A. S., Wood, F., McNulty, S. E., Rogers, J. G., Mark, D. B., Lee, K. L., Mitchell, L. B., Bernstein, R. C., Boehmer, J. P., Carlson, M. D., Anderson, J., Bardy, G. H., Johnson, G. W., & Walsh, M. N. (2010). Response to letter regarding article, impact of implantable cardioverter-defibrillator, amiodarone, and placebo on the mode of death in stable patients with heart failure: Analysis from the sudden cardiac death in heart failure trial. Circulation, 122(15), e487. https://doi.org/10.1161/CIRCULATIONAHA.110.951806